2026年11月4日星期三
M
Küresel Panorama
Küresel haberler
US tech giants' hidden AI debt swells 90% to $3.2tn in 6 months— 日经 Nikkei AsiaFukushima tries to reinvent itself as hub for drones, robots and rockets— 日经 Nikkei AsiaJapan's Yamato targets 'leaner' delivery service in push for profit: president— 日经 Nikkei AsiaNew MUFG digital bank to forgo ATM cards in cybercrime safeguard— 日经 Nikkei AsiaJapan to bolster defenses with unified missile, artillery systems— 日经 Nikkei AsiaNTT to help Japanese companies update at-risk aging IT with AI— 日经 Nikkei Asia5 things to know about the US midterms and what they mean for Asia— 日经 Nikkei AsiaChina's cable-cutting threat reaches Taiwan and the Philippines— 日经 Nikkei AsiaUS tech giants' hidden AI debt swells 90% to $3.2tn in 6 months— 日经 Nikkei AsiaFukushima tries to reinvent itself as hub for drones, robots and rockets— 日经 Nikkei AsiaJapan's Yamato targets 'leaner' delivery service in push for profit: president— 日经 Nikkei AsiaNew MUFG digital bank to forgo ATM cards in cybercrime safeguard— 日经 Nikkei AsiaJapan to bolster defenses with unified missile, artillery systems— 日经 Nikkei AsiaNTT to help Japanese companies update at-risk aging IT with AI— 日经 Nikkei Asia5 things to know about the US midterms and what they mean for Asia— 日经 Nikkei AsiaChina's cable-cutting threat reaches Taiwan and the Philippines— 日经 Nikkei Asia

Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia

Kaynak Nature 生命科学1 gün önce
İçerik özeti

Bu site yalnızca başlık ve özet dizini sunar; tam içerik ve telif hakkı asıl yayıncıya aittir, lütfen okumak için orijinal bağlantıya tıklayın.

Orijinal metne git
Ait olduğu kanal
Bilim
Ait olduğu bölge
Küresel bakış
Orijinal dil
English
Kayıt numarası
science-5e9eca3a

Comments 0 comments

No comments yet. Be the first.

Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia · Küresel Panorama